Specifications table {#s0005}
====================

TableSubject areaBiologyMore specific subject areaProteomics on the Hepatocellular CarcinomaType of dataList of identified proteins as tables (.xls), raw data in websiteHow data was acquiredThe data was acquired by Liquid chromatography mass spectrometry in tandem (LC--MS/MS).The samples were separated by a Acquity UPLC system (Waters Corporation, Milford, MA) and detected by a Nano-Aquity UPLC system (Waters Corporation, Milford, MA) connected to a quadrupole-Orbitrap mass spectrometer (Q-Exactive) (Thermo Fisher Scientific, Bremen, Germany).Data formatFiltered and analyzedExperimental factorsNon-appliedExperimental featuresProteins were extracted from tumor tissues of HCC patients with single and multiple lesions, iTRAQ labeled and then prepared for liquid chromatography-mass spectrometry (LC--MS/MS) analysis.Data source locationFuzhou, China, Mengchao Hepatobiliary Hospital of Fujian Medical UniversityData accessibilityFiltered and analyzed data are supplied here and raw data have also been deposited to the integrated Proteome resources (iProX) with identifier IPX00037601 (<http://www.iprox.org/index>).

Value of the data {#s0010}
=================

•The proteome of hepatocellular carcinoma with single and multiple lesions analyzed using iTRAQ technology.•A total of 5513 proteins (FDR of 1%) were identified which correspond to roughly 27% of the total liver proteome.•The in-depth proteomics analysis of the HCC tumor tissues with a single and multiple lesions might be useful for further study of the mechanisms.

1. Data, experimental design, materials and methods {#s0015}
===================================================

1.1. Data and experimental design {#s0020}
---------------------------------

The data show the lists of proteins identified and quantified in the HCC tumor tissues with single and multiple lesions. The tissues were divided into 4 groups: cancerous tissues from HCC patients with multiple observed lesions (MC group, *n*=30); surrounding noncancerous tissues from HCC patients with multiple observed lesions (MN group, *n*=30); cancerous tissues from primary HCC patients with a single observed lesion (SC group, *n*=30); surrounding noncancerous tissues from primary HCC patients with a single observed lesion (SN group, *n*=30). The detailed characteristics of the selected HCC patients were listed in [Table 1](#t0005){ref-type="table"}. For each group, every 5 individual samples with equal tissue weight were mixed, and then the proteins were extracted from the mixed samples. And then the samples were labeled with the iTRAQ 8-plex reagent as follows: four groups (MC group, MN group, SC group and SN group) were labeled with 113, 114, 115 and 116 isobaric tag, respectively; and the peptides from the biological repetitions of the above 4 groups were labeled with 117, 118, 119 and 121, respectively. The iTRAQ 8-plex labeling was independently repeated 3 times, defining as A, B and C. So we have 6 repeated protein extracts for each group to minimize the individual differences of the patients.

1.2. Materials and methods {#s0025}
--------------------------

Tissue samples, including the cancerous and surrounding noncancerous tissues, were obtained from 30 primary HCC patients with multiple observed lesions and 30 primary HCC patients with a single observed lesion, respectively. All patients have undergone radical surgery at Mengchao Hepatobiliary Hospital of Fujian Medical University from August 2010 to January 2013. The protein from these two type HCC tissues was determined by BCA assay (TransGen Biotech, Beijing, China) following the manufacture's protocol. Afterwards, 100 μg proteins per condition were treated with DTT (8 mM) and iodoacetamide (50 mM) for reduction and alkylation. Afterwards, the proteins were typically digested by sequence-grade modified trypsin (Promega, Madison, WI), and then the resultant peptides mixture was further labeled using chemicals from the iTRAQ reagent kit (AB SCIEX, USA).

The peptide mixture was fractionated by high pH separation using a Acquity UPLC system (Waters Corporation, Milford, MA) connected to a reverse phase column (BEH C18, 1.7 µm, 2.1×50 mm^2^, Waters Corporation, Milford, MA). High pH separation was performed using a linear gradient starting from 5% B to 35% B in 20 min (solution B: 20 mM ammonium formate in 90% ACN, the pH was adjusted to 10.0 with ammonium hydroxide). The column flow rate was maintained at 600 μl/min and column temperature was maintained at room temperature. Finally 40 fractions were collected, and two fractions with the same time interval were pooled together to reduce the fraction numbers, such as 1 and 21, 2 and 22, and so on [@bib2]. Twenty fractions at the end were dried in a vacuum concentrator for further usage.

The fractions were then separated by nano-LC and analyzed by on-line electrospray tandem mass spectrometry. The experiments were performed on a Nano-Aquity UPLC system (Waters Corporation, Milford, MA) connected to a quadrupole-Orbitrap mass spectrometer (Q-Exactive) (Thermo Fisher Scientific, Bremen, Germany) equipped with an online nano-electrospray ion source. 8 μl peptide sample was loaded onto the trap column (Thermo Scientific Acclaim PepMap C18, 100 μm×2 cm)with a flow of 10 μl/min, and subsequently separated on the analytical column (Acclaim PepMap C18, 75 μm×50 cm) with a linear gradient, from 2% D to 40% D in 135 min (solution D: 0.1% formic acid in ACN). The Q-Exactive mass spectrometer was operated in the data-dependent mode to switch automatically between MS and MS/MS acquisition. Survey full-scan MS spectra (*m*/*z* 350--1200) was acquired with a mass resolution of 70 K, followed by 15 sequential high energy collisional dissociation (HCD) MS/MS scans with a resolution of 17.5 K. In all cases, one microscan was recorded using dynamic exclusion of 30 s.

1.3. Data analysis {#s0030}
------------------

All the raw files generated by the Q-Exactive instrument were converted into mzXML and MGF files using the ms convert module in Trans-Proteomic Pipeline (TPP 4.6.2). All MGF files were searched using Mascot (Matrix Science, London, UK; version 2.3.0) against a human_database provided by The Universal Protein Resource (<http://www.uniprot.org/uniprot>, released at 2014-04-10, with 20,264 entries). Using the results from Scaffold_4.3.2, we quantified 5513 proteins in three iTRAQ 8-plex labeling replicates. The complete list of identified proteins in our dataset is shown in [Table S1](#s0055){ref-type="sec"}. The detailed characteristics of proteomes of the primary HCC with single and multiple lesions, including Molecular Weight (MW), Isoelectric Point (PI), Hydrophobicity, exponentially modified Protein Abundance Index (emPAI), Quantitative Clustering, Average Coefficient of Variance (CV), quantification results with percentage variability, were included in the list as well. The distribution of unique peptide numbers per protein, MW, PI and hydrophobicity also clearly showed that the overall proteome datasets of the primary HCC with single and multiple lesions had no strong bias ([Fig. 1](#f0005){ref-type="fig"}).

2. Analysis of the dataset {#s0035}
==========================

2.1. The analysis of the quantitative proteomics {#s0040}
------------------------------------------------

In this dataset, 107 and 330 proteins were classified as differentially expressed in HCC tumor tissues with single and multiple lesions compared to surrounding noncancerous tissues ([Fig. 2](#f0010){ref-type="fig"}A, B). All of the differentially expressed proteins presented a mean expression fold change of ±1.5 (log~2~ 0.58) or even more with a *p* value less than 0.05 (paired *T*-test), meanwhile these proteins should have the same change trends in all six biological replicates. Among these differentially expressed proteins, 71 proteins altered their expression in both HCC types ([Fig. 2](#f0010){ref-type="fig"}C). GO annotation analysis showed that these proteins were the major participants in the oxidation reduction process and the cellular metabolic processes ([Fig. 2](#f0010){ref-type="fig"}D).

2.2. Bioinformatics analysis {#s0045}
----------------------------

The Gene Ontology (GO) annotation and pathway enrichment analysis of all the identified proteins and differentially expressed proteins were implemented using the online tool DAVID (<http://david.abcc.ncifcrf.gov/>). The quantitative iTRAQ ratios of 36 proteins, which dysregulated in MC group comparing to MN group, but these proteins were not dysregulated in primary HCC with a single lesion, were plotted on a heatmap ([Fig. 3](#f0015){ref-type="fig"}A). The names of the dysregulated proteins are listed in [Table 2](#t0010){ref-type="table"}. We further analyzed these protein involved biological process by GO analysis ([Fig. 3](#f0015){ref-type="fig"}C). Meanwhile, 142 up-regulated proteins and 117 down-regulated proteins were specifically appeared in HCC with a single lesion group, but not in HCC with multiple lesions group; and the up and down regulated proteins also form clearly distinct clusters in the heatmap ([Fig. 3](#f0015){ref-type="fig"}B). The list of protein names is also displayed in [Table 3](#t0015){ref-type="table"}. We further analyzed these protein involved biological process by GO analysis ([Fig. 3](#f0015){ref-type="fig"}D). Gene ontology (GO) analysis of the molecular function and cell component of differentially expressed proteins which is only dysregulated in HCC with a single lesion or HCC with multiple lesions are also displayed in [Fig. 4](#f0020){ref-type="fig"}.

The biological functions and signaling pathway annotations of the differentially expressed proteins were analyzed by Ingenuity Pathways Analysis (IPA) software (version 7.5), which is based on the Ingenuity Pathways database. The key functions of the differentially expressed proteins involved in the HCC with single and multiple lesions according to IPA analysis are also displayed in [Fig. 5](#f0025){ref-type="fig"}. The GO annotations, involved signaling pathways and networks were ranked in term of the enrichment of the differentially expressed proteins.

Appendix A. Supplementary material {#s0055}
==================================

Supplementary material
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![The qualities of the proteome dataset. (A) Frequency distribution of the identified proteins with ≥1 unique peptides. (B) Molecular weight distribution of identified proteins proved that there is no bias in the protein extraction process. (C) Isoelectric point distribution of the identified proteins to show the unbias of the protein extraction. (D) Protein hydrophobicity distribution of the identified proteins.](gr1){#f0005}

![The iTRAQ ratio distribution and involved biological processes of the differentially expressed proteins in the HCC with single and multiple lesions. (A) Volcano plot represented the protein abundance changes in the HCC cancerous tissue with multiple lesions comparing to their adjacent noncancerous tissues. A total of 107 dysregulated proteins with fold change ≥1.5 and *p* values \<0.05 were identified. (B) Volcano plot represented the protein abundance changes in the HCC cancerous tissues with a single lesion comparing to their adjacent noncancerous tissue. A total of 330 dysregulated proteins with fold change ≥1.5 and *p* values \<0.05 were identified. (C) Venn diagrams showed the overlaps and number of differentially expressed proteins in the HCC with single and multiple lesions. (D) GO analysis of the involved biological processes of the common dysregulated proteins in both types of the HCC. All of the biological processes were ranked in term of enrichment of the differentially expressed proteins, and the top 10 are presented here.](gr2){#f0010}

![The hierarchical clustering and involved biological processes analysis of differentially expressed proteins in the primary HCC with single and multiple lesions. (A) Hierarchical clustering of the 107 dysregulated proteins in the HCC with multiple lesions (MC vs. MN). (B) Hierarchical clustering of the 330 dysregulated proteins in the HCC with a single lesion (SC vs. SN). (C, D) GO analysis of the dysregulated proteins involved biological processes in the HCC with multiple lesions (C) and in the HCC with a single lesion (D).](gr3){#f0015}

![Gene ontology (GO) function analysis of differentially expressed proteins which is only dysregulated in HCC with a single lesion or HCC with multiple lesions. (A) GO analysis of the molecular function of the proteins which is only differentially expressed in HCC with multiple lesions. (B) GO analysis of the molecular function of the proteins which is only differentially expressed in HCC with a single lesion. (C) GO analysis of the cell component of the proteins which is only differentially expressed in HCC with multiple lesions. (D) GO analysis of the cell component of the proteins which is only differentially expressed in HCC with a single lesion. All of biological processes were ranked in term of the enrichment of the differentially expressed proteins, and the top 10 are presented.](gr4){#f0020}

![The key functions of the differentially expressed proteins involved in the HCC with single and multiple lesions according to IPA analysis. (A) Enriched Functions of the differentially expressed proteins that is only dysregulated in HCC with multiple lesions. (B) Enriched Functions of the differentially expressed proteins that is only dysregulated in HCC with a single lesion. All of pathways were ranked in term of the enrichment of the differentially expressed proteins, and the top 10 were presented.](gr5){#f0025}

###### 

Basic information and characteristics of the HCC patients with a single or multiple observed lesions, who were enrolled in this dataset.

Table 1

  　                          HCC with multiple lesions   HCC with a single lesion
  --------------------------- --------------------------- --------------------------
  Gender                                                  
   Male                       30                          30
   Female                     0                           0
                                                          
  Age (years)                                             
   ≤55                        17                          17
   \>55                       13                          13
                                                          
  AFP (ng/ml)                                             
   ≤400                       12                          20
   \>400                      18                          10
                                                          
  Tumor size (cm)                                         
   ≤5                         9                           6
   5--10                      21                          24
                                                          
  Progression of cirrhosis                                
   None                       3                           5
   Mild                       13                          12
   Moderate                   13                          12
   Severe                     1                           1
                                                          
  Tumor boundaries                                        
   Distinct                   18                          22
   Indistinct                 12                          8
                                                          
  Differentiation degree                                  
   I--II                      8                           4
   II--III                    17                          22
   III--IV                    5                           4
                                                          
  Vascular tumor thrombosis                               
   No                         26                          25
   Yes                        4                           5
                                                          
  Tumor encapsulation                                     
   No                         2                           6
   Incomplete                 14                          10
   Complete                   14                          14

###### 

List of the differentially expressed proteins which is only dysregulated in HCC with multiple lesions.

Table 2

  Differentially expressed proteins                        Gene       Fold change   Fold change
  -------------------------------------------------------- ---------- ------------- -------------
  UTP-glucose-1-phosphate uridylyltransferase              UGP2       0.62          0.68
  Bile acyl-CoA synthetase                                 SLC27A5    0.58          0.67
  Cytochrome P450 2A6                                      CYP2A6     0.6           0.73
  Glycine dehydrogenase (decarboxylating), mitochondrial   GLDC       0.65          0.72
  17-Beta-hydroxysteroid dehydrogenase 13                  HSD17B13   0.56          0.71
  Glycogen \[starch\] synthase, liver                      GYS2       0.65          0.7
  Sequestome-1                                             SQSTM1     1.77          1.59
  4-Hydroxyphenylpyruvate dioxygenase                      HPD        0.63          0.76
  Kynurenine 3-monooxygenase                               KMO        0.56          0.76
  Beta-enolase                                             ENO3       0.64          0.71
  Urocanate hydratase                                      UROC1      0.66          0.76
  Keratin, type I cytkeletal 20                            KRT20      1.53          1.97
  Synembryn-A                                              RIC8A      1.56          1.4
  Cadherin-related family member 2                         CDHR2      0.64          0.78
  Cytochrome P450 2B6                                      CYP2B6     0.64          0.69
  NAD(P)H dehydrogenase \[quinone\] 1                      NQO1       1.89          1.52
  Anterior gradient protein 2 homolog                      AGR2       1.71          1.14
  Peripherin                                               PRPH       0.64          0.7
  Fuce mutarotase                                          FUOM       0.6           0.61
  Coiled-coil domain-containing protein 57                 CCDC57     1.54          1.4
  Gangliide-induced differentiation-associated protein 1   GDAP1      1.51          1.44
  Histone H1.1                                             HIST1H1A   1.62          1.12
  Choline transporter-like protein 2                       SLC44A2    0.65          0.63
  RAS protein activator like-3                             RASAL3     0.63          0.79
  Non-histone chromomal protein HMG-17                     HMGN2      3.06          1.65
  FH1/FH2 domain-containing protein 1                      FHOD1      1.66          1.44
  Copine-6                                                 CPNE6      0.58          0.78
  Myeloblastin                                             PRTN3      1.51          1.94
  24-Hydroxycholesterol 7-alpha-hydroxylase                CYP39A1    0.61          0.71
  Sodium/hydrogen exchanger 10                             SLC9C1     0.63          0.68
  Steroid 17-alpha-hydroxylase/17,20 lyase                 CYP17A1    1.57          2.15
  HLA class I histocompatibility antigen, alpha chain G    HLA-G      0.66          1.08
  MICAL C-terminal-like protein                            MICALCL    0.49          0.4
  Nucleolysin TIA-1 isoform p40                            TIA1       0.66          0.91
  Immunoglobulin-binding protein 1                         IGBP1      1.57          1.63
  Protein FAM171A1                                         FAM171A1   0.59          0.63

###### 

List of the differentially expressed proteins which is only dysregulated in HCC with a single lesion.

Table 3

  Differentially expressed proteins                                         Gene        Fold change   Fold change
  ------------------------------------------------------------------------- ----------- ------------- -------------
  Keratin, type II cytkeletal 8                                             KRT8        0.73          0.62
  Keratin, type I cytkeletal 18                                             KRT18       0.72          0.6
  Tenascin-X                                                                TNXB        0.72          0.65
  C-1-tetrahydrofolate synthase, cytoplasmic                                MTHFD1      0.72          0.56
  Trifunctional enzyme subunit beta, mitochondrial                          HADHB       0.91          0.6
  Acetyl-CoA acetyltransferase, mitochondrial                               ACAT1       0.78          0.61
  Long-chain-fatty-acid--CoA ligase 1                                       ACSL1       0.72          0.65
  Haptoglobin                                                               HP          0.68          0.5
  3-Ketoacyl-CoA thiolase, mitochondrial                                    ACAA2       0.81          0.5
  Non-specific lipid-transfer protein                                       SCP2        0.91          0.65
  Lumican                                                                   LUM         0.86          0.63
  Fatty acid-binding protein, liver                                         FABP1       0.68          0.6
  [d]{.smallcaps}-Beta-hydroxybutyrate dehydrogenase, mitochondrial         BDH1        0.69          0.65
  Betaine--homocysteine S-methyltransferase 1                               BHMT        0.67          0.58
  Putative hexokinase HKDC1                                                 HKDC1       1.28          1.54
  [l]{.smallcaps}-Lactate dehydrogenase A chain                             LDHA        1.24          1.6
  Pyruvate kinase PKM                                                       PKM         1.25          1.59
  X-ray repair crs-complementing protein 6                                  XRCC6       1.36          1.63
  Enoyl-CoA hydratase, mitochondrial                                        ECHS1       0.86          0.55
  Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial                ECH1        0.87          0.65
  ATP synthase subunit d, mitochondrial                                     ATP5H       0.78          0.56
  Laminin subunit beta-1                                                    LAMB1       1.42          1.53
  S-adenylmethionine synthase isoform type-1                                MAT1A       0.74          0.66
  X-ray repair crs-complementing protein 5                                  XRCC5       1.49          1.77
  Electron transfer flavoprotein subunit alpha, mitochondrial               ETFA        0.83          0.65
  ATP-citrate synthase                                                      ACLY        1.16          1.7
  Myeloperoxidase                                                           MPO         1.37          1.58
  Glucose-6-phosphate isomerase                                             GPI         1.14          1.83
  Villin-1                                                                  VIL1        1.36          1.75
  Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial       ACADSB      0.86          0.61
  Endoplasmic reticulum resident protein 29                                 ERP29       0.77          0.59
  Superoxide dismutase \[Cu--Zn\]                                           SOD1        0.83          0.64
  C4b-binding protein alpha chain                                           C4BPA       1.24          1.62
  DnaJ homolog subfamily B member 9                                         DNAJB9      0.81          0.45
  3-Ketoacyl-CoA thiolase, peroxisomal                                      ACAA1       0.8           0.63
  Decorin                                                                   DCN         0.8           0.64
  Transketolase                                                             TKT         1.42          1.66
  Ferritin light chain                                                      FTL         0.73          0.62
  Elongation factor 1-gamma                                                 EEF1G       1.18          1.55
  Cytochrome b-c1 complex subunit 7                                         UQCRB       0.79          0.53
  Transferrin receptor protein 1                                            TFRC        1.49          1.89
  Glycerol-3-phosphate dehydrogenase \[NAD(+)\], cytoplasmic                GPD1        0.77          0.64
  Peroxiredoxin-4                                                           PRDX4       0.7           0.64
  Mimecan                                                                   OGN         0.77          0.62
  Cytochrome c oxidase subunit 6B1                                          COX6B1      0.79          0.58
  NADH dehydrogenase \[ubiquinone\] flavoprotein 2, mitochondrial           NDUFV2      0.82          0.55
  Phenylalanine-4-hydroxylase                                               PAH         0.68          0.66
  6-Phosphogluconate dehydrogenase, decarboxylating                         PGD         1.22          1.73
  ATP synthase subunit O, mitochondrial                                     ATP5O       0.93          0.66
  Cytochrome b-c1 complex subunit Rieske, mitochondrial                     UQCRFS1     0.85          0.65
  Cytochrome c oxidase subunit 5B, mitochondrial                            COX5B       0.79          0.55
  Dehydrogenase/reductase SDR family member 4                               DHRS4       0.94          0.6
  Gamma-glutamyltransferase 5                                               GGT5        0.67          0.6
  Sulfotransferase 1A1                                                      SULT1A1     0.81          0.58
  Carboxypeptidase D                                                        CPD         1.44          1.61
  Spliceome RNA helicase DDX39B                                             DDX39B      1.18          1.53
  Core histone macro-H2A.1                                                  H2AFY       1.48          1.51
  Polymerase I and transcript release factor                                PTRF        0.83          0.62
  Apolipoprotein D                                                          APOD        0.84          0.66
  ATP synthase-coupling factor 6, mitochondrial                             ATP5J       0.78          0.56
  Glucose-6-phosphate 1-dehydrogenase                                       G6PD        1.43          1.61
  2-Oxoisovalerate dehydrogenase subunit alpha, mitochondrial               BCKDHA      0.83          0.63
  NADH dehydrogenase \[ubiquinone\] 1 beta subcomplex subunit 10            NDUFB10     0.83          0.58
  Glycine N-acyltransferase                                                 GLYAT       0.73          0.6
  Cytochrome c oxidase subunit 5A, mitochondrial                            COX5A       0.82          0.59
  DNA replication licensing factor MCM3                                     MCM3        1.5           1.62
  Ribonuclease UK114                                                        HRSP12      0.82          0.65
  Phenazine biosynthesis-like domain-containing protein                     PBLD        0.72          0.58
  Asparagine--tRNA ligase, cytoplasmic                                      NARS        1.43          1.67
  Lamin-B receptor                                                          LBR         1.36          1.68
  Polypeptide N-acetylgalactaminyltransferase 2                             GALNT2      1.22          1.58
  Paralemmin-3                                                              PALM3       0.71          0.63
  EGF-containing fibulin-like extracellular matrix protein 1                EFEMP1      1.37          1.51
  Heme-binding protein 1                                                    HEBP1       0.83          0.54
  Apolipoprotein C-III                                                      APOC3       0.92          0.66
  Phosphoglucomutase-2                                                      PGM2        1.16          1.85
  Complement factor H-related protein 5                                     CFHR5       0.89          0.63
  [l]{.smallcaps}-Lactate dehydrogenase B chain                             LDHB        1.2           1.62
  Serine--tRNA ligase, cytoplasmic                                          SARS        1.09          1.55
  ATP synthase subunit e, mitochondrial                                     ATP5I       0.79          0.56
  Creatine kinase B-type                                                    CKB         0.95          1.92
  NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 5            NDUFA5      0.74          0.53
  NADH dehydrogenase \[ubiquinone\] iron--sulfur protein 8, mitochondrial   NDUFS8      0.89          0.66
  Desmin                                                                    DES         0.71          0.51
  DNA replication licensing factor MCM6                                     MCM6        1.34          1.54
  Serum deprivation-response protein                                        SDPR        0.79          0.55
  Acyl-coenzyme A synthetase ACSM3, mitochondrial                           ACSM3       0.75          0.6
  Clathrin light chain B                                                    CLTB        0.88          0.65
  Probable [d]{.smallcaps}-lactate dehydrogenase, mitochondrial             LDHD        0.75          0.63
  Beta-2-microglobulin                                                      B2M         0.87          0.63
  Four and a half LIM domains protein 1                                     FHL1        0.86          0.66
  NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 2            NDUFA2      0.85          0.58
  Perilipin-2                                                               PLIN2       1.23          1.65
  NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 8            NDUFA8      0.72          0.47
  Tubulointerstitial nephritis antigen-like                                 TINAGL1     0.81          0.61
  Farnesyl pyrophosphate synthase                                           FDPS        1.37          1.6
  Minor histocompatibility antigen H13                                      HM13        1.3           1.68
  Glutathione peroxidase 1                                                  GPX1        0.81          0.64
  DNA-(apurinic or apyrimidinic site) lyase                                 AX1         1.34          1.67
  Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3                        PLOD3       1.15          1.58
  Angiotensinogen                                                           AGT         1.14          1.55
  Transmembrane protein 2                                                   TMEM2       1.1           1.51
  Alpha/beta hydrolase domain-containing protein 14B                        ABHD14B     0.86          0.66
  EF-hand domain-containing protein D1                                      EFHD1       0.81          0.65
  Protein mago nashi homolog 2                                              MAGOHB      1.3           1.73
  3-Hydroxyanthranilate 3,4-dioxygenase                                     HAAO        0.79          0.66
  Cofilin-2                                                                 CFL2        0.78          0.64
  NADH dehydrogenase \[ubiquinone\] iron--sulfur protein 6, mitochondrial   NDUFS6      0.82          0.47
  NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 12           NDUFA12     0.8           0.62
  Alpha-fetoprotein                                                         AFP         1.02          2.13
  Proliferating cell nuclear antigen                                        PCNA        1.43          1.62
  Transmembrane 9 superfamily member 4                                      TM9SF4      1.35          1.54
  NADH dehydrogenase \[ubiquinone\] iron--sulfur protein 5                  NDUFS5      0.82          0.56
  Nuclear cap-binding protein subunit 1                                     NCBP1       1.34          1.55
  Dermatopontin                                                             DPT         0.74          0.62
  Glycine N-methyltransferase                                               GNMT        0.8           0.65
  Ataxin-10                                                                 ATXN10      1.38          1.57
  UPF0553 protein C9orf64                                                   C9orf64     1.41          1.64
  BRO1 domain-containing protein BROX                                       BROX        1.38          1.51
  NADH dehydrogenase \[ubiquinone\] iron--sulfur protein 4, mitochondrial   NDUFS4      0.78          0.5
  [l]{.smallcaps}-Serine dehydratase/[l]{.smallcaps}-threonine deaminase    SDS         1.01          0.65
  Protein transport protein Sec23B                                          SEC23B      1.39          1.65
  Mitochondrial import inner membrane translocase subunit Tim8 A            TIMM8A      0.82          0.56
  Nicastrin                                                                 NCSTN       1.29          1.53
  Cytochrome P450 3A7                                                       CYP3A7      1.38          1.94
  40S ribomal protein S15                                                   RPS15       1.08          0.55
  Integrin alpha-IIb                                                        ITGA2B      1.1           0.65
  Acyl-CoA:lysophosphatidylglycerol acyltransferase 1                       LPGAT1      1.14          1.51
  Apolipoprotein L1                                                         APOL1       1.36          1.61
  Peptidyl-prolyl cis--trans isomerase FKBP2                                FKBP2       0.9           0.66
  Complement factor H-related protein 1                                     CFHR1       0.7           0.63
  Plasma serine protease inhibitor                                          SERPINA5    1.08          1.52
  Mitochondrial import inner membrane translocase subunit Tim13             TIMM13      0.81          0.48
  Tropomodulin-1                                                            TMOD1       0.83          0.64
  Myin regulatory light polypeptide 9                                       MYL9        0.82          0.62
  ER lumen protein retaining receptor 1                                     KDELR1      1.1           1.58
  NAD-dependent malic enzyme, mitochondrial                                 ME2         1.33          1.6
  Ceramide synthase 2                                                       CERS2       1.47          1.51
  Monocarboxylate transporter 4                                             SLC16A3     1.44          1.66
  Glutaredoxin-1                                                            GLRX        0.82          0.66
  Collagen alpha-6(VI) chain                                                COL6A6      0.75          0.63
  Group XIIB secretory phospholipase A2-like protein                        PLA2G12B    0.79          0.59
  Latent-transforming growth factor beta-binding protein 2                  LTBP2       1.33          1.53
  Myin-7                                                                    MYH7        1.14          2.46
  15 kDa selenoprotein                                                      15-Sep      0.69          0.58
  Metalloproteinase inhibitor 1                                             TIMP1       1.33          1.52
  Protein RCC2                                                              RCC2        1.37          1.65
  NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 7            NDUFA7      0.86          0.57
  Calmegin                                                                  CLGN        1.41          1.75
  Apolipoprotein(a)                                                         LPA         0.74          0.64
  Elongation factor 1-alpha 2                                               EEF1A2      1.13          1.74
  Cytochrome c oxidase protein 20 homolog                                   COX20       1.38          1.63
  Translin                                                                  TSN         1.2           1.57
  Folate receptor beta                                                      FOLR2       0.72          0.65
  Secretory carrier-associated membrane protein 3                           SCAMP3      1.38          1.53
  Chitinase-3-like protein 1                                                CHI3L1      1.11          1.86
  Mitochondrial intermembrane space import and assembly protein 40          CHCHD4      0.9           0.57
  Fibrocystin-L                                                             PKHD1L1     0.71          0.55
  Girdin                                                                    CCDC88A     0.82          0.38
  Flap endonuclease 1                                                       FEN1        1.3           1.74
  Solute carrier family 43 member 3                                         SLC43A3     1.29          1.65
  Complement factor H-related protein 3                                     CFHR3       0.84          0.59
  Cleavage stimulation factor subunit 3                                     CSTF3       1.39          1.88
  Protein kinase C delta-binding protein                                    PRKCDBP     0.76          0.54
  Transmembrane protein 176B                                                TMEM176B    1.32          1.62
  60 kDa lysophospholipase                                                  ASPG        0.7           0.62
  Spermidine synthase                                                       SRM         1.2           1.51
  B-cell receptor-associated protein 29                                     BCAP29      1.11          1.56
  Retinol dehydrogenase 10                                                  RDH10       1.36          1.58
  PDZ and LIM domain protein 2                                              PDLIM2      0.8           0.6
  Sodium/potassium-transporting ATPase subunit beta-3                       ATP1B3      1.46          1.56
  Uncharacterized protein C19orf52                                          C19orf52    1.36          1.53
  Transmembrane protein 70, mitochondrial                                   TMEM70      1.24          1.51
  Insulin-like growth factor 2 mRNA-binding protein 2                       IGF2BP2     1.41          1.77
  C-reactive protein                                                        CRP         1.2           1.83
  Importin subunit alpha-1                                                  KPNA2       1.33          2.77
  COX assembly mitochondrial protein 2 homolog                              CMC2        0.82          0.61
  Retinoic acid receptor responder protein 2                                RARRES2     1.38          1.54
  Oncoprotein-induced transcript 3 protein                                  OIT3        0.71          0.59
  Ficolin-1                                                                 FCN1        0.9           0.65
  StAR-related lipid transfer protein 5                                     STARD5      0.76          0.56
  Transmembrane protein 14C                                                 TMEM14C     1.33          1.64
  P2X purinoceptor 4                                                        P2RX4       1.39          1.58
  Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA    MINA        1.28          1.63
  Myeloid leukemia factor 2                                                 MLF2        0.81          0.58
  C4b-binding protein beta chain                                            C4BPB       1.16          1.65
  Astrocytic phosphoprotein PEA-15                                          A15         1.07          1.53
  Pituitary tumor-transforming gene 1 protein-interacting protein           PTTG1IP     1.36          1.68
  Unconventional myin-XIX                                                   MYO19       1.4           1.55
  Ras-related protein Rab-3D                                                RAB3D       1.49          1.61
  F-box only protein 22                                                     FBXO22      1.15          1.61
  UPF0364 protein C6orf211                                                  C6orf211    1.33          1.59
  PRA1 family protein 2                                                     PRAF2       1.28          1.53
  Serine incorporator 1                                                     SERINC1     1.41          1.53
  Spermatogenesis-defective protein 39 homolog                              VIPAS39     1.33          1.53
  Ryanodine receptor 1                                                      RYR1        0.91          1.52
  AP-1 complex subunit gamma-like 2                                         AP1G2       1.4           1.65
  Hexokinase-2                                                              HK2         1.37          1.97
  Uncharacterized protein C2orf42                                           C2orf42     1.19          1.53
  Phospholipid transfer protein                                             PLTP        1.05          2.05
  PC4 and SFRS1-interacting protein                                         PSIP1       1.3           1.53
  Rho guanine nucleotide exchange factor 18                                 ARHGEF18    1.48          1.56
  Acylphosphatase-2                                                         ACYP2       0.82          0.6
  Claudin-1                                                                 CLDN1       1.05          1.68
  Neutral amino acid transporter B(0)                                       SLC1A5      1.2           2
  CB1 cannabinoid receptor-interacting protein 1                            CNRIP1      0.91          0.66
  Cytolic Fe--S cluster assembly factor NUBP2                               NUBP2       0.84          0.6
  Sortilin                                                                  SORT1       1.12          1.51
  UPF0729 protein C18orf32                                                  C18orf32    1.15          1.77
  Protein YIPF4                                                             YIPF4       1.33          1.6
  Cell growth regulator with EF hand domain protein 1                       CGREF1      1.11          1.54
  Presenilins-associated rhomboid-like protein, mitochondrial               PARL        1.3           1.59
  Bactericidal permeability-increasing protein                              BPI         1.23          1.66
  Protein S100-A1                                                           S100A1      1.27          1.63
  Ammonium transporter Rh type A                                            RHAG        2.34          1.83
  Pleckstrin homology domain-containing family G member 3                   PLEKHG3     1.37          1.52
  Putative methyltransferase NSUN5                                          NSUN5       0.71          0.59
  Secretory carrier-associated membrane protein 4                           SCAMP4      1.32          1.61
  Cochlin                                                                   COCH        1.31          2.12
  tRNA (guanine(10)-N2)-methyltransferase homolog                           TRMT11      1.33          2
  Protein YIPF3                                                             YIPF3       1.27          1.54
  Synaptogyrin-1                                                            SYNGR1      1.34          1.73
  Ubiquitin carboxyl-terminal hydrolase isozyme L1                          UCHL1       1.26          1.57
  MAP kinase-activated protein kinase 2                                     MAPKAPK2    1.41          1.52
  Proteoglycan 3                                                            PRG3        0.69          0.65
  Bcl-2 homologous antagonist/killer                                        BAK1        1.3           1.7
  TNF receptor-associated factor 6                                          TRAF6       1.03          0.66
  Ethanolamine-phosphate phospho-lyase                                      ETNPPL      0.66          0.46
  Proto-oncogene tyrine-protein kinase Src                                  SRC         1.29          1.62
  Folate transporter 1                                                      SLC19A1     1.3           1.81
  Platelet factor 4                                                         PF4         0.76          0.54
  Chloride intracellular channel protein 5                                  CLIC5       1             1.52
  Negative elongation factor E                                              NELFE       1.32          1.64
  RNA polymerase II-associated protein 1                                    RPAP1       1.26          1.65
  Zinc transporter SLC39A7                                                  SLC39A7     1.67          2
  Ankyrin repeat domain-containing protein 24                               ANKRD24     0.8           1.65
  Centromal protein of 85 kDa-like                                          CEP85L      0.26          0.65
  Caspase-3                                                                 CASP3       1.22          1.68
  Peroxisomal leader peptide-processing protease                            TYSND1      1.3           1.6
  tRNA (guanine(37)-N1)-methyltransferase                                   TRMT5       1.26          1.86
  Mitochondrial inner membrane organizing system protein 1                  MINOS1      1.31          1.52
  Coiled-coil domain-containing protein 153                                 CCDC153     1.36          2.47
  Conserved oligomeric Golgi complex subunit 8                              COG8        1.23          1.56
  Vesicle transport protein SFT2B                                           SFT2D2      1.13          1.51
  F-box only protein 10                                                     FBXO10      0.71          0.63
  Muskelin                                                                  MKLN1       1.09          1.57
  Tuftelin-interacting protein 11                                           TFIP11      1.27          1.52
  Sulfotransferase 1C2                                                      SULT1C2     1.15          1.62
  Zinc transporter ZIP1                                                     SLC39A1     1.45          1.91
  Proton-coupled folate transporter                                         SLC46A1     1.19          1.52
  Putative heat shock protein HSP 90-beta 2                                 HSP90AB2P   1.29          2.25
  Asparagine synthetase \[glutamine-hydrolyzing\]                           ASNS        1.21          2.7
  Ubiquitin carboxyl-terminal hydrolase 38                                  USP38       0.64          0.52
  Glycogen synthase kinase-3 alpha                                          GSK3A       1.34          1.71
  Coiled-coil domain-containing protein 69                                  CCDC69      0.8           0.66
  Retinoid-binding protein 7                                                RBP7        0.95          1.51
  Signal-transducing adaptor protein 2                                      STAP2       1.21          1.59
  Soluble calcium-activated nucleotidase 1                                  CANT1       1.5           2
  Threonine synthase-like 2                                                 THNSL2      0.65          0.48
